Stockreport

Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain

Evolus, Inc.  (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
PDF Launching in one of the five largest aesthetic toxin injectable markets in Europe1 as part of the company’s geographic expansion strategyEvolus to provide Nuceiva® for d [Read more]